XML 63 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share
6 Months Ended
Mar. 28, 2020
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following is a reconciliation of the numerators and denominators of the basic and diluted per share computations for income from continuing operations (in thousands except share and per share amounts).
Three Months EndedSix Months Ended
March 28, 2020March 28, 2020
IncomeSharesPer ShareIncomeSharesPer Share
Basic EPS:
     Net income available to common shareholders$42,704  54,281  $0.79  $38,287  54,517  $0.70  
Effect of dilutive securities (1):
     Options to purchase common stock—  343  (0.01) —  368  (0.01) 
     Restricted shares—  328  —  —  335  —  
Diluted EPS:
     Net income available to common shareholders$42,704  54,952  $0.78  $38,287  55,220  $0.69  
(1) The potential effects of stock awards were excluded from the diluted earnings per share calculation for the three months ended December 28, 2019, because their inclusion in a net loss period would be anti-dilutive to the earnings per share calculation.
Three Months EndedSix Months Ended
March 30, 2019March 30, 2019
IncomeSharesPer ShareIncomeSharesPer Share
Basic EPS:
     Net income available to common shareholders$42,391  57,050  $0.74  $44,194  56,976  $0.78  
Effect of dilutive securities:
     Options to purchase common stock—  609  (0.01) —  639  (0.01) 
     Restricted shares—  367  —  —  398  (0.01) 
Diluted EPS:
     Net income available to common shareholders$42,391  58,026  $0.73  $44,194  58,013  $0.76  

Options to purchase 3.4 million shares of common stock at prices ranging from $10.63 to $38.10 per share were outstanding at March 28, 2020, and options to purchase 2.8 million shares of common stock at prices ranging from $8.56 to $38.10 per share were outstanding at March 30, 2019.

For the three months ended March 28, 2020 and March 30, 2019, 1.5 million and 1.8 million options outstanding were not included in the computation of diluted earnings per share because the option exercise prices were greater than the average market price of the common shares and therefore, the effect of including these options would be antidilutive.

For the six months ended March 28, 2020 and March 30, 2019, 1.2 million and 1.8 million options outstanding were not included in the computation of diluted earnings per share because the option exercise prices were greater than the average market price of the common shares and therefore, the effect of including these options would be antidilutive.